Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New study tests if menstrual cycle timing boosts Quit-Smoking success

NCT ID NCT05515354

First seen Mar 29, 2026 · Last updated Jun 22, 2026 · Updated 14 times

Summary

This study tests whether starting nicotine replacement therapy (patches, gum, or lozenges) at a specific time in the menstrual cycle helps women quit smoking. About 1,200 women who smoke daily and have regular periods will be assigned to start their quit attempt during the follicular phase, luteal phase, or at their usual time. The goal is to see if cycle-timed quitting leads to higher abstinence rates.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SUBSTANCE USE DISORDERS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Centre for Addiction and Mental Health, Nicotine Dependence Clinic

    RECRUITING

    Toronto, Ontario, M6J 1H4, Canada

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Nicotine replacement therapy (patch, gum, lozenge)

What this could lead to

If successful, this could show that timing quit attempts to the menstrual cycle improves smoking cessation rates in women.

What could go wrong

This is a large Phase 4 trial, but the effect may be small or not generalizable to all women. Success depends on adherence and individual cycle variability.

Conditions

The condition(s) this trial relates to.

nicotine dependence Smoking Cessation substance-related disorder Tobacco Smoking

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.